Detalhe da pesquisa
1.
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome.
Pulm Pharmacol Ther
; 79: 102201, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841351
2.
CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort.
Am J Respir Crit Care Med
; 205(12): 1440-1448, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363592
3.
Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort.
Respir Res
; 20(1): 148, 2019 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31299951
4.
Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI.
EJNMMI Res
; 9(1): 113, 2019 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858293